Searching across hundreds of databases
Deeper exploration of the brain's vast synaptic networks will require new tools for high-throughput structural and molecular profiling of the diverse populations of synapses that compose those networks. Fluorescence microscopy (FM) and electron microscopy (EM) offer complementary advantages and disadvantages for single-synapse analysis. FM combines exquisite molecular discrimination capacities with high speed and low cost, but rigorous discrimination between synaptic and non-synaptic fluorescence signals is challenging. In contrast, EM remains the gold standard for reliable identification of a synapse, but offers only limited molecular discrimination and is slow and costly. To develop and test single-synapse image analysis methods, we have used datasets from conjugate array tomography (cAT), which provides voxel-conjugate FM and EM (annotated) images of the same individual synapses. We report a novel unsupervised probabilistic method for detection of synapses from multiplex FM (muxFM) image data, and evaluate this method both by comparison to EM gold standard annotated data and by examining its capacity to reproduce known important features of cortical synapse distributions. The proposed probabilistic model-based synapse detector accepts molecular-morphological synapse models as user queries, and delivers a volumetric map of the probability that each voxel represents part of a synapse. Taking human annotation of cAT EM data as ground truth, we show that our algorithm detects synapses from muxFM data alone as successfully as human annotators seeing only the muxFM data, and accurately reproduces known architectural features of cortical synapse distributions. This approach opens the door to data-driven discovery of new synapse types and their density. We suggest that our probabilistic synapse detector will also be useful for analysis of standard confocal and super-resolution FM images, where EM cross-validation is not practical.
Pubmed ID: 28414801 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Non profit bioscience research organization in Seattle, Washington dedicated to accelerating research globally and sharing that data within the science community. Allen Institute for Brain Science, Allen Institute for Cell Science, Allen Institute for Immunology, and The Paul G. Allen Frontiers Group are four divisions of this Institute with commitment to open science model within its research institutes.
View all literature mentionsNIH is the nations medical research agency - making important medical discoveries that improve health and save lives. The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. Helping to lead the way toward important medical discoveries that improve peoples health and save lives, NIH scientists investigate ways to prevent disease as well as the causes, treatments, and even cures for common and rare diseases. NIH research impacts: * child and teen health, * men's health, * minority health, * seniors' health, * women's health, and * wellness and lifestyle issues. Composed of 27 Institutes and Centers, the NIH provides leadership and financial support to researchers in every state and throughout the world.
View all literature mentionsAn independent federal agency created by Congress to promote the progress of science; to advance the national health, prosperity, and welfare; to secure the national defense They are the funding source for approximately 20 percent of all federally supported basic research conducted by America''s colleges and universities. In many fields such as mathematics, computer science and the social sciences, NSF is the major source of federal backing. NSF leadership has two major components: a director who oversees NSF staff and management responsible for program creation and administration, merit review, planning, budget and day-to-day operations; and a 24-member National Science Board (NSB) of eminent individuals that meets six times a year to establish the overall policies of the foundation.The director and all Board members serve six year terms. Each of them, as well as the NSF deputy director, is appointed by the President of the United States and confirmed by the U.S. Senate. At present, NSF has a total workforce of about 2,100 at its Arlington, Va., headquarters, including approximately 1,400 career employees, 200 scientists from research institutions on temporary duty, 450 contract workers and the staff of the NSB office and the Office of the Inspector General. NSF is the only federal agency whose mission includes support for all fields of fundamental science and engineering, except for medical sciences. They are tasked with keeping the United States at the leading edge of discovery in areas from astronomy to geology to zoology. So, in addition to funding research in the traditional academic areas, the agency also supports high-risk, high pay-off ideas, novel collaborations and numerous projects that may seem like science fiction today, but which the public will take for granted tomorrow. And in every case, they ensure that research is fully integrated with education so that today''s revolutionary work will also be training tomorrow''s top scientists and engineers NSF''s task of identifying and funding work at the frontiers of science and engineering is not a top-down process.
View all literature mentionsThis monoclonal targets PSD95 (D27E11) XP Rabbit mAb
View all literature mentionsThis monoclonal targets GABA(A)R, Alpha1
View all literature mentionsThis monoclonal targets Gephyrin
View all literature mentionsThis monoclonal targets GAD2 (D5G2) XP Rabbit mAb
View all literature mentionsThis monoclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis polyclonal targets GABA
View all literature mentionsThis monoclonal targets GluA2/GluR2 glutamate receptor
View all literature mentionsThis polyclonal targets Glutamate receptor 1
View all literature mentionsThis monoclonal targets GluN2B/NR2B glutamate receptor
View all literature mentionsThis monoclonal targets NMDAR1
View all literature mentionsThis polyclonal targets VGLUT2
View all literature mentionsThis polyclonal targets VGLUT1
View all literature mentionsThis monoclonal targets Synapsin-1 (D12G5) XP Rabbit mAb
View all literature mentionsThis monoclonal targets PSD95 (D27E11) XP Rabbit mAb
View all literature mentionsThis polyclonal targets VGLUT2
View all literature mentionsThis polyclonal targets VGLUT1
View all literature mentionsThis monoclonal targets Synapsin-1 (D12G5) XP Rabbit mAb
View all literature mentionsThis monoclonal targets GABA(A)R, Alpha1
View all literature mentionsThis monoclonal targets Gephyrin
View all literature mentionsThis monoclonal targets GAD2 (D5G2) XP Rabbit mAb
View all literature mentionsThis monoclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis polyclonal targets GABA
View all literature mentionsThis polyclonal targets VGLUT2
View all literature mentionsThis monoclonal targets GluA2/GluR2 glutamate receptor
View all literature mentionsThis polyclonal targets Glutamate receptor 1
View all literature mentionsThis monoclonal targets GluN2B/NR2B glutamate receptor
View all literature mentionsThis polyclonal targets VGLUT1
View all literature mentionsThis monoclonal targets NMDAR1
View all literature mentionsThis monoclonal targets Synapsin-1 (D12G5) XP Rabbit mAb
View all literature mentionsThis monoclonal targets PSD95 (D27E11) XP Rabbit mAb
View all literature mentionsThis polyclonal targets VGLUT1
View all literature mentionsThis polyclonal targets VGLUT2
View all literature mentionsThis monoclonal targets GluN2B/NR2B glutamate receptor
View all literature mentionsThis monoclonal targets GABA(A)R, Alpha1
View all literature mentionsThis monoclonal targets GABA(A)R, Alpha1
View all literature mentionsThis monoclonal targets Gephyrin
View all literature mentionsThis monoclonal targets Gephyrin
View all literature mentionsThis monoclonal targets GABA(A)R, Alpha1
View all literature mentionsThis monoclonal targets GAD2 (D5G2) XP Rabbit mAb
View all literature mentionsThis monoclonal targets GAD2 (D5G2) XP Rabbit mAb
View all literature mentionsThis monoclonal targets Gephyrin
View all literature mentionsThis monoclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis monoclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis monoclonal targets GAD2 (D5G2) XP Rabbit mAb
View all literature mentionsThis polyclonal targets GABA
View all literature mentionsThis polyclonal targets GABA
View all literature mentionsThis monoclonal targets VGAT (cytoplasmic domain)
View all literature mentionsThis polyclonal targets Glutamate receptor 1
View all literature mentionsThis monoclonal targets GluA2/GluR2 glutamate receptor
View all literature mentionsThis monoclonal targets GluA2/GluR2 glutamate receptor
View all literature mentionsThis polyclonal targets GABA
View all literature mentionsThis monoclonal targets GluN2B/NR2B glutamate receptor
View all literature mentionsThis polyclonal targets Glutamate receptor 1
View all literature mentionsThis monoclonal targets NMDAR1
View all literature mentionsThis monoclonal targets GluN2B/NR2B glutamate receptor
View all literature mentionsThis monoclonal targets NMDAR1
View all literature mentionsThis polyclonal targets Glutamate receptor 1
View all literature mentionsThis monoclonal targets GluA2/GluR2 glutamate receptor
View all literature mentionsThis monoclonal targets GluN2B/NR2B glutamate receptor
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
